BAFNAPHAR (India) Financial Diagnostics

Macroaxis technical analysis interface gives you tools to check potential technical drivers of BAFNAPHAR NS as well as the relationship between them. The company executives did not add any value to BAFNAPHAR investors in January. However, most investors can still diversify their portfolios with BAFNAPHAR NS to hedge your portfolio against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.0. The very small Stock volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about BAFNAPHAR as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis BAFNAPHAR price relationship with some important fundamental indicators such as market cap and management efficiency. Check also Trending Equities.

BAFNAPHAR Note

The company had not issued any dividends in recent years.

BAFNAPHAR NS Alerts

BAFNAPHAR NS is not yet fully synchronised with the market data
BAFNAPHAR NS has some characteristics of a very speculative penny stock

BAFNAPHAR Technical and Predictive Indicators

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Portfolio Rebalancing

Also Currentnly Active

Purchased over 100 shares of
few hours ago
Traded for 9.04
Purchased over 100 shares of
few hours ago
Traded for 20.95
Purchased over 100 shares of
few hours ago
Traded for 4.25
Check also Trending Equities. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Search macroaxis.com